Kimchi Microbes Show Probiotic Promise as Scientists Isolate Three New Latilactobacillus sakei Strains

In the bustling world of fermented foods, few products have captured scientific and popular attention quite like kimchi, the iconic Korean staple of salted and fermented vegetables. Beyond its fiery flavor and cultural significance, kimchi has long been suspected of harboring bacteria with genuine health-promoting potential. Now, a team of researchers at Gachon University in the Republic of Korea has taken a systematic step toward testing that suspicion, reporting the isolation and characterization of three strains of Latilactobacillus sakei from kimchi that display a suite of traits associated with probiotic bacteria. The study, published in the journal 3 Biotech, offers one of the more thorough functional evaluations of kimchi-derived L. sakei to date, combining classical microbiology with molecular identification and cell-based safety assays.

The research began with an ambitious screening campaign. The team collected lactic acid bacteria from several varieties of kimchi, ultimately isolating forty distinct bacterial candidates. Because kimchi is a naturally fermented ecosystem, its microbial residents are diverse, and not every lactic acid bacterium is a promising probiotic candidate. To narrow the field, the researchers employed a three-tier identification strategy. First, they used random amplified polymorphic DNA profiling, a genetic fingerprinting technique that distinguishes closely related isolates by generating strain-specific banding patterns. They then constructed phylogenetic trees based on the 16S ribosomal RNA gene, the standard molecular barcode for bacterial identification, and confirmed species identity with species-specific polymerase chain reaction assays targeting diagnostic marker sequences.

This molecular gauntlet winnowed the forty isolates down to three confirmed L. sakei strains, designated RKA, RKC, and TAB. The choice of species was deliberate. L. sakei has an interesting dual reputation: it is well known in the food industry as a bioprotective organism that can suppress spoilage and pathogenic bacteria in chilled meats, yet it is also increasingly studied as a probiotic candidate, with prior clinical work exploring its effects on conditions ranging from dry eye disease to knee osteoarthritis. Strains isolated from fermented foods are considered attractive probiotic sources because they are already adapted to survive in harsh, acidic, and competitive environments, conditions that resemble the journey through the human gastrointestinal tract.

That survival ability was precisely what the Gachon team set out to quantify. A candidate probiotic must endure stomach acid and bile salts if it is to reach the intestine alive. When the researchers exposed their strains to acidic conditions, survival ranged from 33 to 85 percent depending on the strain, while tolerance to bile salts fell between 49 and 68 percent. These are meaningful figures, indicating that a substantial fraction of cells could withstand simulated digestive stresses. The team also measured traits linked to the ability of bacteria to colonize the gut lining. Cell surface hydrophobicity, a proxy for adhesion to intestinal epithelial cells, ranged from 11.5 to 25.6 percent with ethyl acetate and from 21.0 to 47.4 percent with hexane, while auto-aggregation, the tendency of bacterial cells to clump together and form protective biofilms, spanned 12.6 to 44.0 percent across the three strains.

Safety evaluation is arguably the most critical gatekeeper in probiotic development, and here the researchers ran a battery of tests. Hemolytic activity, the ability of bacteria to rupture red blood cells, a hallmark of many pathogens, was assessed, and none of the strains displayed the gamma-hemolytic patterns that would raise concern. Antibiotic susceptibility testing, conducted according to established clinical standards, showed that the strains were sensitive to most of the antibiotics examined, including carbenicillin, clindamycin, chloramphenicol, ampicillin, erythromycin, and tetracycline. The one caveat is that the strains showed resistance to cefoxitin and metronidazole. The authors note that such intrinsic resistance patterns are not unusual among lactic acid bacteria, but antibiotic resistance profiles remain a standard item on the safety checklist that regulators and the International Scientific Association for Probiotics and Prebiotics expect candidates to clear before any human application.

Beyond survival and safety, the study probed the functional chemistry of the bacteria, focusing on their cell-free supernatants, the liquid fractions left behind after cells are removed, which contain the metabolites the bacteria secrete. These supernatants demonstrated notable antioxidant capacity, scavenging 34.1 to 37.9 percent of DPPH radicals and 41.6 to 43.1 percent of ABTS radicals in standard colorimetric assays. The crude preparations, which included cellular material, showed weaker activity, ranging from 3.9 to 8.7 percent for DPPH and 11.0 to 17.3 percent for ABTS. Importantly, the researchers backed up these biochemical observations with genetics, detecting the presence of sod and katA genes, which encode superoxide dismutase and catalase, enzymes central to neutralizing reactive oxygen species. All three strains also tolerated hydrogen peroxide at various concentrations, reinforcing the picture of organisms equipped with robust oxidative stress defenses.

Perhaps the most striking result concerned antimicrobial activity. The cell-free supernatant of strain RKC outperformed its counterparts, inhibiting the growth of an impressive roster of problematic microbes: Escherichia coli, Bacillus subtilis, Pseudomonas aeruginosa, Staphylococcus aureus, and even the fungal pathogen Candida albicans. This broad-spectrum antagonism likely reflects the production of organic acids, hydrogen peroxide, and possibly bacteriocins, ribosomally synthesized antimicrobial peptides that many lactic acid bacteria deploy against competitors. The finding resonates with a growing body of literature showing that kimchi-derived lactic acid bacteria can disrupt biofilms formed by foodborne pathogens on seafood and food processing surfaces, suggesting potential applications not only as dietary supplements but also as natural biopreservatives in the food industry.

To assess whether these bacterial products could pose a risk to human cells, the team tested both crude preparations and cell-free supernatants against Caco-2 cells, a widely used laboratory model derived from human colon adenocarcinoma that mimics the intestinal barrier. The results were reassuring: no significant cytotoxicity was observed. This is an essential data point, because a probiotic candidate that harms intestinal cells in vitro would be a non-starter regardless of its other virtues. Combined with the hemolysis and antibiotic susceptibility results, the cytotoxicity data build a preliminary but coherent safety profile for the three strains, positioning them as credible candidates for the next stages of evaluation.

The authors are careful to frame their findings as a starting point rather than a finish line. They explicitly call for genome-based characterization of the selected strains, which would involve whole-genome sequencing to identify virulence factors, functional gene clusters, and transferable antibiotic resistance genes at a resolution that phenotypic tests cannot match. Such genomic work has become the expected standard in modern probiotic research, and comparative analyses of L. sakei genomes are already revealing how niche adaptation, whether in meat, fish, or fermented vegetables, shapes the functional repertoire of this species. Until that deeper characterization is complete, the study stands as a rigorous demonstration that the tangy, spicy world of kimchi continues to yield microbes of genuine biotechnological interest, and that strain RKC, with its standout antimicrobial activity, may be the one to watch as the field moves from screening bench to functional food development.

Subject of Research: Probiotic potential of Latilactobacillus sakei strains isolated from kimchi

Article Title: Screening, isolation, and identification of Latilactobacillus sakei strains from kimchi with potential probiotic properties

Article References: Sharma, P., Sharma, A., & Lee, H.-J. (2026). Screening, isolation, and identification of Latilactobacillus sakei strains from kimchi with potential probiotic properties. 3 Biotech, 16(9), Article 405. https://doi.org/10.1007/s13205-026-04978-7

Image Credits: AI Generated

DOI: 10.1007/s13205-026-04978-7

Keywords: kimchi, Latilactobacillus sakei, probiotics, lactic acid bacteria, antimicrobial activity, antioxidant, gut microbiota, cell-free supernatant, 16S rRNA, food fermentation, Caco-2 cells, biopreservation